共 54 条
[1]
Goto E(2010)Hemorrhagic complications of percutaneous radiofrequency ablation for liver tumors J Clin Gastroenterol 44 374-80
[2]
Tateishi R(2017)Thrombocytopenia in chronic liver disease Liver Int 37 778-93
[3]
Shiina S(2019)Lusutrombopag for the treatment of thrombocytopenia in patients with chronic liver disease undergoing invasive procedures (L-PLUS 2) Hepatology 70 1336-48
[4]
Masuzaki R(2019)Lusutrombopag reduces need for platelet transfusion in patients with thrombocytopenia undergoing invasive procedures Clin Gastroenterol Hepatol 17 1192-200
[5]
Enooku K(2019)A randomized controlled trial of lusutrombopag in japanese patients with chronic liver disease undergoing radiofrequency ablation J Gastroenterol 54 171-81
[6]
Sato T(2020)Lusutrombopag is effective and safe in patients with chronic liver disease and severe thrombocytopenia: a multicenter retrospective study BMC Gastroenterol 20 427-22
[7]
Peck-Radosavljevic M(2007)Staging of hepatocellular carcinoma: assesment of the japanese TNM and AJCC/UICC TNM systems in a cohort of 12,772 patients in Japan Ann Surg 245 909-3
[8]
Peck-Radosavljevic M(2019)Efficacy and safety of repeated use of lusutrombopag prior to radiofrequency ablation in patients with recurrent hepatocellular carcinoma and thrombocytopenia Hepatol Res 49 590-9
[9]
Simon K(2018)Relationship between response to lusutrombopag and splenic volume World J Gastroenterol 24 5271-undefined
[10]
Iacobellis A(2019)Real-life experience of lusutrombopag for cirrhotic patients with low platelet counts being prepared for invasive procedures PLoS ONE 14 e0211122-undefined